Growing Industry Presence PDA's leadership in the pharmaceutical manufacturing sector, with over 10,500 members worldwide, indicates strong industry influence and a large potential customer base for specialized products and services related to pharmaceutical science, regulation, and technology.

Strategic Leadership Transition The upcoming change in CEO from Glenn E. Wright to Craig Elliott provides an opportunity to engage with senior management for partnership or sponsorship opportunities aligned with PDA’s future strategic directions.

Event Engagement PDA actively participates in industry events such as PDA Week 2026 and sustainable packaging workshops, which serve as key platforms for introducing new offerings, networking with decision-makers, and showcasing innovative solutions.

Content Development Focus The recent launch of three new technical documents by PDA highlights their commitment to scientific innovation and best practices, suggesting potential collaboration opportunities for content providers, training solutions, or regulatory consulting.

Revenue and Industry Scale With reported revenues of up to $500 million, PDA demonstrates significant market presence and purchasing power, making it a valuable target for high-quality pharmaceutical manufacturing solutions, advanced safety technologies, and compliance-related services.